IL6 and infection: IL-6 deletion increased median survival of KrasG12D; p53flox/flox mice (P<0.01) (Table 1) despite substantial lung tumor burden in both KrasG12D; p53flox/flox and KrasG12D; p53flox/flox; IL-6-/- mice 12 weeks post-infection (Figure 3A and B).